Method for screening and identifying tumor/testis antigens based on monoclonal antibodies with spermatogenic cell specificities
A monoclonal antibody and testicular antigen technology, which can be used in measurement devices, instruments, scientific instruments, etc., can solve problems such as the inability to meet tumor immunology and the inability to effectively identify differentially expressed proteins.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0028] The method for screening and identification of tumor / testis antigens provided by the present invention uses human sperm cells as immunogens, applies lymphocyte hybridoma technology to prepare monoclonal antibodies, and uses immunohistochemical method to screen human sperm cell-specific monoclonal antibodies; On the horizontal level, the expression distribution of the antigen molecules recognized by the screened monoclonal antibodies in tumor tissues and other normal tissues was investigated. Based on this, immunohistochemical staining was used to select monoclonal antibodies against the regular expression of tumor / testis antigens (that is, anti-human sperm cell-specific monoclonal antibodies that only react with human tumor tissues but not with normal human tissues), As a candidate antibody recognizing tumor / testis antigen; through immunoprecipitation-mass spectrometry and other modern proteomics techniques, screen and identify the new tumor / testis antigen molecule recog...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com